Topiramate-induced maculopathy in IgG4-related disease

Report, Article English OPEN
DaCosta, Joanna; Younis,Saad;
(2016)
  • Publisher: Dove Press
  • Journal: Drug, Healthcare and Patient Safety,volume 8,pages59-63 (issn: 1179-1365, eissn: 1179-1365)
  • Related identifiers: doi: 10.2147/DHPS.S105962, pmc: PMC4908941
  • Subject: R5-920 | Medicine (General) | Case Report | maculopathy | IgG4 disease | Drug, Healthcare and Patient Safety | topiramate
    mesheuropmc: eye diseases | genetic structures

Joanna DaCosta,1,2 Saad Younis1 1Ophthalmology Department, Imperial College Healthcare NHS Trust, Western Eye Hospital, 2Barts Health NHS Trust, Whipps Cross University Hospital, London, UK Abstract: This report describes a case of reversible topiramate-induced maculop... View more
  • References (19)
    19 references, page 1 of 2

    1. Lyseng-Williamson KA, Yang LP. Topiramate: a review of its use in the treatment of epilepsy. Drugs. 2007;67(15):2231-2256.

    2. Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate induced bilateral anterior uveitis associated with hypopyon formation. Ocul Immunol Inflamm. 2011;19(1):86-88.

    3. Maryanoff BE, Nortey SO, Gardocki JF, Shank RP, Dodgson SP. Anti-convulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methyleethylidene)-beta-D-fructopyranose sulfamate and related compounds. J Med Chem. 1987;30(5):880-887.

    4. Gupta PP, Thacker AK, Haider J, Dhawan S, Pandey N, Pandey AK. Assessment of topiramate's efficacy and safety in epilepsy. J Neurosci. Rural Pract. 2014;5(2):144-148.

    5. Shank RP, Maryanoff BE. Molecular pharmacodynamics, clinical therapeutics and pharmacokinetics of topiramate. CNS Neurosci Ther. 2008;14(2):120-142.

    6. Asensio-SánchezVM,Torreblanca-AgüeraB,Martínez-CalvoS,CalvoMJ, Rodríguez R. Toxicidad oftalmológica severa por Topamax. [Severe ocular side effects with Topamax]. Arch Soc Esp Oftalmol. 2006;81(6): 345-348. Spanish.

    7. Tsui I, Casper D, Chou CL, Tsang SH. Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy. Doc Ophthalmol. 2008;116(1):57-60.

    8. Kjellström S, Bruun A, Isaksson B, Eriksson T, Andréasson S, Ponjavic V. Retinal function and histopathology in rabbits treated with Topiramate. Doc Ophthalmol. 2006;113(3):179-186.

    9. White HS. Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache. 2005;45 Suppl 1:S48-S56.

    10. GualtieriW, Janula J.Topiramate maculopathy. Int Ophthalmol. 2013;33(1): 103-106.

  • Similar Research Results (5)
  • Metrics
    No metrics available
Share - Bookmark